1.Gómez-Ambrosi J., Silva C., Galofré JC., Escalada J., Santos S., Gil MJ. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring). 2011. 19:1439–44.
2.Freisling H., Arnold M., Soerjomataram I., O'Doherty MG., Ordóñez-Mena JM., Bamia C. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individu-al participant data of seven prospective cohorts in Europe. Br J Cancer. 2017. 116:1486–97.
3.Bigaard J., Frederiksen K., Tj⊘nneland A., Thomsen BL., Overvad K., Heitmann BL. Body fat and fat-free mass and all-cause mortality. Obes Res. 2004. 12:1042–9.
4.Finkelstein EA., Trogdon JG., Cohen JW., Dietz W. Annual medical spending attributable to obesity: payer-and ser-vice-specific estimates. Health Aff (Millwood). 2009. 28:w822–31.
5.Dietz W., Santos-Burgoa C. Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring). 2020. 28:1005.
6.Lim S., Shin SM., Nam GE., Jung CH., Koo BK. Proper man-agement of people with obesity during the COVID-19 pandemic. J Obes Metab Syndr. 2020. 29:84–98.
7.Lim S., Lim H., Després JP. Collateral damage of the COVID-19 pandemic on nutritional quality and physical activity: perspective from South Korea. Obesity (Silver Spring). 2020. 28:1788–90.
8.Lim S., Bae JH., Kwon HS., Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical man-agement. Nat Rev Endocrinol. 2021. 17:11–30.
9.Andreoli A., Garaci F., Cafarelli FP., Guglielmi G. Body composition in clinical practice. Eur J Radiol. 2016. 85:1461–8.
10.Kim KM., Jang HC., Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016. 31:643–50.
11.Ganapathy A., Nieves JW. Nutrition and sarcopenia-what do we know? Nutrients. 2020. 12:1755.
12.Prado CM., Lieffers JR., McCargar LJ., Reiman T., Sawyer MB., Martin L. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008. 9:629–35.
13.Hsu KJ., Liao CD., Tsai MW., Chen CN. Effects of exercise and nutritional intervention on body composition, metabolic health, and physical performance in adults with sarcopenic obesity: a meta-analysis. Nutrients. 2019. 11:2163.
14.Lim S., Kim JH., Yoon JW., Kang SM., Choi SH., Park YJ. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010. 33:1652–4.
15.Campa F., Toselli S., Mazzilli M., Gobbo LA., Coratella G. Assessment of body composition in athletes: a narrative review of available methods with special reference to quantitative and qualitative bioimpedance analysis. Nutrients. 2021. 13:1620.
16.Anderson LJ., Erceg DN., Schroeder ET. Utility of mul-tifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women. Nutr Res. 2012. 32:479–85.
17.Moon JR., Stout JR., Smith-Ryan AE., Kendall KL., Fukuda DH., Cramer JT. Tracking fat-free mass changes in elderly men and women using single-frequency bioimped-ance and dual-energy X-ray absorptiometry: a four-com-partment model comparison. Eur J Clin Nutr. 2013. 67(Suppl 1):S40–6.
18.Neovius M., Hemmingsson E., Freyschuss B., Uddén J. Bioelectrical impedance underestimates total and truncal fatness in abdominally obese women. Obesity (Silver Spring). 2006. 14:1731–8.
19.Gába A., Kapuš O., Cuberek R., Botek M. Comparison of multi- and single-frequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of body composition in post-menopausal women: effects of body mass index and accelerometer-determined physical activity. J Hum Nutr Diet. 2015. 28:390–400.
20.Chen KT., Chen YY., Wang CW., Chuang CL., Chiang LM., Lai CL. Comparison of standing posture bioelectrical impedance analysis with DXA for body composition in a large, healthy Chinese population. PLoS One. 2016. 11:e0160105.
21.Lukaski HC., Siders WA. Validity and accuracy of regional bioelectrical impedance devices to determine whole-body fatness. Nutrition. 2003. 19:851–7.
22.LaForgia J., Gunn S., Withers RT. Body composition: valid-ity of segmental bioelectrical impedance analysis. Asia Pac J Clin Nutr. 2008. 17:586–91.
23.Nickerson BS., Tinsley GM. Utilization of BIA-derived bone mineral estimates exerts minimal impact on body fat estimates via multicompartment models in physically active adults. J Clin Densitom. 2018. 21:541–9.
24.Kyle UG., Bosaeus I., De Lorenzo AD., Deurenberg P., Elia M., Manuel Gómez J. Bioelectrical impedance analy-sis-part II: utilization in clinical practice. Clin Nutr. 2004. 23:1430–53.
25.Lee DH., Park KS., Ahn S., Ku EJ., Jung KY., Kim YJ. Comparison of abdominal visceral adipose tissue area measured by computed tomography with that estimated by bioelectrical impedance analysis method in Korean subjects. Nutrients. 2015. 7:10513–24.
26.Park KS., Lee DH., Lee J., Kim YJ., Jung KY., Kim KM. Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. 2016. 30:343–9.
27.Lee SY., Ahn S., Kim YJ., Ji MJ., Kim KM., Choi SH. Comparison between dual-energy X-ray absorptiometry and bioelectrical impedance analyses for accuracy in measuring whole body muscle mass and appendicular skeletal muscle mass. Nutrients. 2018. 10:738.